Author： Barton Matthias Dubey Raghvendra K Traupe Tobias
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.11, Iss.3, 2002-03, pp. : 329-332
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Oral contraceptives: VT risk quantified
Reactions Weekly, Vol. 1, Iss. 1266, 2009-01 ,pp. :
Access to resources
Recommend
Low risk of arterial thrombosis with hormonal contraceptives
Reactions Weekly, Vol. 1, Iss. 1408, 2012-01 ,pp. :
Oral contraceptives: Pulmonary thromboembolism and renal vein thrombosis: case report
Reactions Weekly, Vol. 1, Iss. 1245, 2009-01 ,pp. :
Oral contraceptives and risk of systemic lupus erythematosus
Reactions Weekly, Vol. 1, Iss. 1254, 2009-01 ,pp. :
No increased risk of breast cancer with oral contraceptives
Inpharma, Vol. 1, Iss. 1345, 2002-01 ,pp. :